Description

The use of artificial intelligence (AI) in the area of medical diagnostics and medical devices.

The service consists of designing a set of pharmacophores, enabling the selection of biologically active compounds targeting a specific molecular target from databases. Proprietary software is used to design the pharmacophores, allowing prediction of receptor binding sites based on molecular dynamics simulations in a cosolvent environment and artificial intelligence-based solutions that optimise the spatial distribution of pharmacophore-defining features.